Science Explorer Back to mapMap
Discussion
Company · Sunnyvale · United States

Theron Pharmaceuticals (United States)

Research works
6
▼ 100% vs 2018-21
Citations
183
29.7 per fractional work
Top-10% rate
9.7%
all institutions 10.0%
Open access
16%
world 40%
International
5%
world 18%
Theron Pharmaceuticals (United States)

Not ranked overall: Theron Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Theron Pharmaceuticals (United States) work in?

In all years, 52% of research at Theron Pharmaceuticals (United States) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (15%), Computer Science (13%). It does 1.4× the world's share of Health Sciences.

Health Sciences: 3 fractional works · 52.4% of its workMedicine: 3 fractional works · 52.4% of its workPhysiology: 1 fractional works · 16.3% of its workPsychiatry and Mental health: 1 fractional works · 10.9% of its workRheumatology: 1 fractional works · 10.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 5.4% of its workSurgery: 0 fractional works · 5.4% of its workPharmacology: 0 fractional works · 1.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.8% of its workLife Sciences: 1 fractional works · 23.4% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 15.3% of its workMolecular Biology: 1 fractional works · 10.9% of its workBiochemistry: 0 fractional works · 2.8% of its workBiophysics: 0 fractional works · 1.8% of its workNeuroscience: 0 fractional works · 5.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 2.8% of its workNeurology: 0 fractional works · 2.8% of its workImmunology and Microbiology: 0 fractional works · 2.8% of its workVirology: 0 fractional works · 2.8% of its workPhysical Sciences: 1 fractional works · 18.9% of its workComputer Science: 1 fractional works · 13.5% of its workComputational Theory and Mathematics: 1 fractional works · 13.5% of its workChemistry: 0 fractional works · 5.4% of its workOrganic Chemistry: 0 fractional works · 5.4% of its workSocial Sciences: 0 fractional works · 5.4% of its workDecision Sciences: 0 fractional works · 5.4% of its workManagement Science and Operations Research: 0 fractional works · 5.4% of its workALL ITS WORKTheronPharmaceuticals…6fractional works, all years
Life Sciences23%Physical Sciences19%Health Sciences52%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 7 fields, with their numbers
    1. Medicine352.4%
    1. Biochemistry, Genetics and Molecular Biology115.3%
    2. Neuroscience05.4%
    3. Immunology and Microbiology02.8%
    1. Computer Science113.5%
    2. Chemistry05.4%
    1. Decision Sciences05.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from Theron Pharmaceuticals (United States)?

    The most cited paper from Theron Pharmaceuticals (United States) is "Elevated oxidative stress in models of normal brain aging and Alzheimer's disease" (D. Allan Butterfield, Beverly J. Howard, Servet M. Yatin et al., 1999), with 148 citations. Next come "Amyloid β-peptide inhibits Na+-dependent glutamate uptake" (38) and "CPI-1189 inhibits interleukin 1β-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its neuroprotective properties?" (17).

    Most cited papers
    #PaperReleasedCitations
    1 Elevated oxidative stress in models of normal brain aging and Alzheimer's disease D. Allan Butterfield, Beverly J. Howard, Servet M. Yatin et al. · Life Sciences Oct 1999 148
    2 Amyloid β-peptide inhibits Na+-dependent glutamate uptake Christopher M. Lauderback, Marni E. Harris‐White, Yaning Wang et al. · Life Sciences Oct 1999 38
    3 CPI-1189 inhibits interleukin 1β-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its neuroprotective properties? Kenneth Hensley, Kent A. Robinson, Quentin N. Pye et al. · Neuroscience Letters Mar 2000 17
    4 Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia Marc Cantillon, Robert M. J. Ings, Laxminarayan Bhat · Clinical and Translational Science Open access 10 Apr 2018 10
    All 4 most cited papers, with filters and sorting

    Which research topics does Theron Pharmaceuticals (United States) publish most on?

    By volume: Alzheimer's disease research and treatments, Attention Deficit Hyperactivity Disorder, Fuzzy and Soft Set Theory and semigroups and automata theory.

    1. 1 Alzheimer's disease research and treatments Physiology 1 works
    2. 2 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
    3. 3 Fuzzy and Soft Set Theory Management Science and Operations Research 0 works
    4. 4 semigroups and automata theory Computational Theory and Mathematics 0 works
    5. 5 Advanced Algebra and Logic Computational Theory and Mathematics 0 works
    6. 6 Surfactants and Colloidal Systems Organic Chemistry 0 works
    7. 7 GDF15 and Related Biomarkers Rheumatology 0 works
    8. 8 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
    9. 9 Cardiovascular Syncope and Autonomic Disorders Surgery 0 works
    10. 10 Connexins and lens biology Molecular Biology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available16.2%not open83.8%

    World: 40% of research is openly available.

    with international co-authors5.4%domestic only94.6%

    World: 18% is written across borders.

    How has Theron Pharmaceuticals (United States)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    2000200520102015
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Other research institutions in Sunnyvale

    All research institutions in Sunnyvale

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Theron Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.